Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.

Tau imaging: early progress and future directions

Villemagne, Victor L, Fodero-Tavoletti, Michelle T, Masters, Colin L, Rowe, Christopher C · 2015 · The Lancet Neurology

Abstract

Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration. Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes. Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time. Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers. Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(14)70252-2

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 101 references

Research works printed but not linked: 3

  1. Mohorko, 2008, Tau protein and human tauopathies: an overview, Zdrav Vestn, 77, 35
  2. Barrio, 1999, PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe, J Labelled Comp Radiopharm, 42, S194
  3. Okamura, 2014, Characterization of 18F-THK-5351, a novel PET tracer for imaging tau pathology in Alzheimer's disease, Eur J Nucl Med Mol Imaging, 41, S260

Cited by

See all 502

Metadata

Authors
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C.
Affiliations
The University of Melbourne (AU)
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2015-01
Volume
14
Issue
1
Pages
114-124
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2090523774
Cited by
501
References
101
Citations by year
2026: 21 · 2025: 18 · 2024: 16 · 2023: 31 · 2022: 25 · 2021: 40 · 2020: 48 · 2019: 46 · 2018: 48 · 2017: 72 · 2016: 90 · 2015: 43
FWCI
8.10
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Health and Medical Research Council
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
tau imaging, tau aggregation, tauopathy, Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, frontotemporal lobar degeneration, neurodegeneration, biomarkers, anti-tau therapy, neuroimaging
MeSH terms
Brain, Humans, Biomarkers, tau Proteins, Neurodegenerative Diseases, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tau imaging: early progress and future directions. https://app.cochat.ai/papers/10.1016/s1474-4422(14)70252-2
The paper
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C. (2015). Tau imaging: early progress and future directions. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70252-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.